It is possible that early during infection enhanced complement activation leads to strong immune responses leading to initiation of severe COVID-19, or that the attenuation of complement-induced inflammation by antibodies in severe cases is less efficient due to antibody glycosylation or single nucleotide polymorphisms in genes involved in CD32/FcγRII signaling. Here, FCGR2B is linked to COVID-19.